Insights

Reset

ADVI insights

Insights,

| Ashis Kumar Das, PhD, MD, MPH - Director

Why is Medicare Data Central to IRA Negotiations?

Insights,

| Tyler Seville, MPA - Senior Manager

The Unintended Consequences of Drug Pricing Policies on Orphan Drug Development

Insights,

ADVI Analysis: HRSA 340B Covered Entity Audits
ADVI Angle Vertical

Insights,

| Allison Schneider, MHA - Director

Prescription Drug Affordability Boards: Access Concerns and Implications for Rare Diseases and Conditions
View All

Case Studies

Case Study: Rare Disease State Policy Engagement

Case Study: Medicare Part D Liability Model 

Case Study: Understanding the Impact of the MFPs for IPAY 2026

Case Study: Strengthening Positioning for IRA Drug Price Negotiation
View All

Events

Events ADVI Health Experts Attending AVBCC 2025
Events ADVI Health Attending Meeting on the Mesa 2025
Events ADVI Health Attending Cure SMA Annual Conference
ADVI Health at Access Forum Events ADVI Health is Attending Access Forum US
Events ADVI Health is Attending ISPOR Annual 2025
Events ADVI Health is Attending Asembia’s AXS25 Summit
View All

News

In The News Tara Southwell Shares Insights on the Budget Reconciliation Bill with Pink Sheet
In The News ADVI’s Lindsay Bealor Greenleaf Joins Managed Healthcare Executive’s Webinar on the Current State of Healthcare
In The News Lindsay Bealor Greenleaf Discusses Trump’s Recent Executive Order in Health Payer Specialist
In The News ADVI Health’s Research Included in Nature Journal ‘NPJ Breast Cancer’
In The News ADVI Health appoints Sandy Royden to its Board of Directors
In The News John Coster Discusses GLP-1 Coverage Among Medicare and Medicaid with Pink Sheet
View All

Videos

ADVI Expert Shares Insight on Recent Policy Developments: OBBA, IRA Negotiation, and HRSA

ADVI Expert John Coster Shares Insights from ACCESS Forum 2025: Medicare Drug Pricing

ADVI Experts Lindsay Greenleaf and Alicia Silver Share Insight After ACCESS Forum 2025 Panels

Amanda Speller Shares Insight on ADVI’s Recent Study Analyzing Access to Precision Medicine and Oncology
View All